{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:57:24Z","timestamp":1781679444579,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015640","name":"Tongji Hospital","doi-asserted-by":"publisher","award":["TJH-202203015"],"award-info":[{"award-number":["TJH-202203015"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015640","name":"Tongji Hospital","doi-asserted-by":"publisher","award":["TJ-IRB202401024"],"award-info":[{"award-number":["TJ-IRB202401024"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003397","name":"Huazhong University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071685"],"award-info":[{"award-number":["82071685"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303516"],"award-info":[{"award-number":["82303516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303188"],"award-info":[{"award-number":["82303188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cellsig.2025.112183","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:41:20Z","timestamp":1761183680000},"page":"112183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathway"],"prefix":"10.1016","volume":"136","author":[{"given":"Yi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didi","family":"Zhuansun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexiong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9579","key":"10.1016\/j.cellsig.2025.112183_bb0005","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.cellsig.2025.112183_bb0010","first-page":"1699","article-title":"MYCN protein expression as a predictor of neuroblastoma prognosis","volume":"3","author":"Chan","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112183_bb0015","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with MYC","volume":"8","author":"Meyer","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112183_bb0020","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1016\/j.celrep.2017.11.090","article-title":"Association with aurora-a controls N-MYC-dependent promoter escape and pause release of RNA polymerase II during the cell cycle","volume":"21","author":"B\u00fcchel","year":"2017","journal-title":"Cell Rep."},{"issue":"4653","key":"10.1016\/j.cellsig.2025.112183_bb0025","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.6719137","article-title":"Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage","volume":"224","author":"Brodeur","year":"1984","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.cellsig.2025.112183_bb0030","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.cellsig.2025.112183_bb0035","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1073\/pnas.81.15.4940","article-title":"Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma","volume":"81","author":"Schwab","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2025.112183_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112183_bb0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2159-8290.CD-17-0273","article-title":"The expanding world of N-MYC-driven tumors","volume":"8","author":"Rickman","year":"2018","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112183_bb0050","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/s41588-018-0191-z","article-title":"Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry","volume":"50","author":"Durbin","year":"2018","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112183_bb0055","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s13046-022-02563-3","article-title":"SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma","volume":"41","author":"Tan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112183_bb0060","article-title":"Therapy resistance in neuroblastoma: mechanisms and reversal strategies","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112183_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","article-title":"Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy","volume":"24","author":"Reed","year":"1998","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cellsig.2025.112183_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175030","article-title":"Neuroblastoma: essential genetic pathways and current therapeutic options","volume":"926","author":"Salemi","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112183_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.118","article-title":"p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment","volume":"4","author":"Marengo","year":"2013","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112183_bb0080","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1073\/pnas.91.6.2250","article-title":"Cloning and characterization of two members of the vertebrate Dlx gene family","volume":"91","author":"Simeone","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112183_bb0085","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.stem.2015.09.002","article-title":"Rapid conversion of fibroblasts into functional forebrain GABAergic interneurons by direct genetic reprogramming","volume":"17","author":"Colasante","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112183_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mcn.2003.10.004","article-title":"Defective neuronogenesis in the absence of Dlx5","volume":"25","author":"Perera","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112183_bb0095","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1080\/15548627.2017.1327927","article-title":"MTOR controls genesis and autophagy of GABAergic interneurons during brain development","volume":"13","author":"Ka","year":"2017","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112183_bb0100","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","article-title":"Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development","volume":"89","author":"Otto","year":"1997","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.cellsig.2025.112183_bb0105","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1242\/dev.126.17.3795","article-title":"Craniofacial, vestibular and bone defects in mice lacking the distal-less-related gene Dlx5","volume":"126","author":"Acampora","year":"1999","journal-title":"Development"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112183_bb0110","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcb.20958","article-title":"Regulation of osteoblast differentiation by transcription factors","volume":"99","author":"Komori","year":"2006","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112183_bb0115","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/nn.2371","article-title":"Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry","volume":"12","author":"Bond","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112183_bb0120","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41593-024-01611-9","article-title":"Spatial enhancer activation influences inhibitory neuron identity during mouse embryonic development","volume":"27","author":"Dvoretskova","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112183_bb0125","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1523\/JNEUROSCI.23-02-00568.2003","article-title":"DLX5 regulates development of peripheral and central components of the olfactory system","volume":"23","author":"Long","year":"2003","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.cellsig.2025.112183_bb0130","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1523\/JNEUROSCI.5963-09.2010","article-title":"Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons","volume":"30","author":"Wang","year":"2010","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112183_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13123005","article-title":"DLX genes: roles in development and cancer","volume":"13","author":"Tan","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112183_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.10.039","article-title":"Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth","volume":"167","author":"Hu","year":"2016","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.cellsig.2025.112183_bb0145","doi-asserted-by":"crossref","first-page":"9246","DOI":"10.1093\/nar\/gkab679","article-title":"Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma","volume":"49","author":"Huang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2025.112183_bb0150","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1186\/1471-2407-10-649","article-title":"Mutually exclusive expression of DLX2 and DLX5\/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231","volume":"10","author":"Morini","year":"2010","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112183_bb0155","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1158\/1078-0432.CCR-07-1523","article-title":"Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients","volume":"14","author":"Kato","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112183_bb0160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00401-021-02341-z","article-title":"Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state","volume":"142","author":"Kochat","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112183_bb0165","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112183_bb0170","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/0008-5472.CAN-06-2201","article-title":"Activation of Akt predicts poor outcome in neuroblastoma","volume":"67","author":"Opel","year":"2007","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112183_bb0175","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112183_bb0180","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1586\/14737140.8.5.757","article-title":"AKT pathway in neuroblastoma and its therapeutic implication","volume":"8","author":"Sartelet","year":"2008","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112183_bb0185","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1517\/14728222.11.12.1611","article-title":"Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor\/TrkB signal transduction pathway","volume":"11","author":"Li","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112183_bb0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41588-018-0044-9","article-title":"Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma","volume":"50","author":"Zeid","year":"2018","journal-title":"Nat. Genet."},{"issue":"D1","key":"10.1016\/j.cellsig.2025.112183_bb0195","doi-asserted-by":"crossref","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","article-title":"JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles","volume":"50","author":"Castro-Mondragon","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.cellsig.2025.112183_bb0200","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","article-title":"Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas","volume":"313","author":"Seeger","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"12 Pt 1","key":"10.1016\/j.cellsig.2025.112183_bb0205","first-page":"6217","article-title":"Enhanced expression of the N-myc gene in Wilms\u2019 tumors","volume":"46","author":"Nisen","year":"1986","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112183_bb0210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ijc.2910450403","article-title":"N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS","volume":"45","author":"Dias","year":"1990","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112183_bb0215","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/labinvest.3780280","article-title":"Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization","volume":"81","author":"Hui","year":"2001","journal-title":"Lab. Investig."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112183_bb0220","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1073\/pnas.83.4.1092","article-title":"Human small-cell lung cancers show amplification and expression of the N-myc gene","volume":"83","author":"Nau","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112183_bb0225","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1073\/pnas.0405495102","article-title":"The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma","volume":"102","author":"Slack","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.cellsig.2025.112183_bb0230","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1158\/0008-5472.CAN-05-0607","article-title":"High mobility group A1 is a molecular target for MYCN in human neuroblastoma","volume":"65","author":"Giannini","year":"2005","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112183_bb0235","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112183_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2006.09.006","article-title":"Molecular mechanisms of resistance and toxicity associated with platinating agents","volume":"33","author":"Rabik","year":"2007","journal-title":"Cancer Treat. Rev."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825005984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825005984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:40:17Z","timestamp":1781678417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825005984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"alternative-id":["S0898656825005984"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112183","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112183"}}